Diabetes
BEMER for Diabetes
Supporting microcirculation in metabolic health management.
About this condition
Diabetes impairs the body's ability to regulate blood glucose, leading to progressive damage of small blood vessels (microangiopathy). This vascular damage underlies many of the serious complications of diabetes — including neuropathy, retinopathy, and impaired wound healing.
How BEMER helps
BEMER Physical Vascular Therapy stimulates microcirculation — the flow of blood through the smallest vessels. In people with diabetes, this can support improved tissue oxygenation, enhanced nutrient delivery to peripheral tissues, and faster healing of minor wounds and ulcers.
Key benefits
Please note: Multiple lines of clinical evidence support BEMER's use in diabetes-related complications. The AFB multi-centre study (n=28) showed 75% positive outcomes in diabetes mellitus at 7 weeks. Klopp's controlled study (IfM Berlin, 2008) demonstrated significant improvement in five microcirculatory parameters in geriatric diabetics with polyneuropathy from day 8–10 — including increased blood-cell-perfused microvessels on intravital microscopy and reduced leukocyte adhesion to vessel walls. Sosna (Thomayer University Hospital, Prague) documented improved outcomes in diabetic macular edema in compliant patients, with accelerated resorption of macular edema following laser treatment. Olszewsky (2000) documented complete closure of a neuropathic diabetic plantar foot ulcer after 2 years of failed IV vasopressin and pressure-relief treatment. The Schönfeld study noted improved insulin sensitivity as a spontaneously reported secondary benefit. Across the compendium, BEMER's most consistent diabetic outcomes are in microvascular complications — neuropathy, retinopathy, and foot ulcers — where impaired circulation is the primary driver.